Clin-e-cal ltd
Tariq Aslam has a diverse work experience in the field of ophthalmology and interface technologies. Tariq is currently employed as a Professor of Ophthalmology and Interface Technologies at The University of Manchester since August 2019. In this role, they are responsible for leading the IOVS MSc Retina course.
Additionally, Tariq has worked as a Consultant Ophthalmologist for the NHS. The exact starting and ending dates for this role are not specified.
Tariq has also served as the Editor in Chief for Ophthalmology and Therapy since January 2018.
Furthermore, Tariq has been the Director of Clin-e-cal ltd since January 2016.
Recently, they joined GiveVision as the Director of Clinical Research in March 2021.
Overall, Tariq Aslam's work experience highlights their expertise in ophthalmology, academia, editorial work, and clinical research.
Tariq Aslam holds an MA(Oxon), MB.Ch.B, FRCSEd(Ophth), DM(Oxon), and a Ph.D from the University of Oxford. Tariq'sfield of study during this time is not specified. Tariq also earned a Doctor of Philosophy (PhD) in Computing Applications from Heriot-Watt University from 2010 to 2013. Additionally, they obtained a DM (Oxon) in Ophthalmology from the University of Oxford from 2001 to 2004. Before that, Tariq Aslam completed a Master's degree in Physiological Sciences from the University of Oxford, although the specific start and end years are not provided.
This person is not in any teams
Clin-e-cal ltd
Clin-e-cal is a digital health company developing smartphone apps to train and monitor inhaler use, focusing on correct technique and adherence. Using our unique Sound Response, acoustic analysis technology we have launched our first app, Rafi-Tone, aimed at helping young children accept their inhaler and allowing their parents to feel reassured. Rafi-Tone works alongside Able spacer and whistle mask which has been optimised for use with young children. We have several apps in development aimed at coaching correct technique and monitoring adherence with inhalers. Through collaborative development, this technology can provide a complete solution for two of the biggest issues in respiratory medicine in an economic and user-friendly manner.